Fidelity SPDR Advertisement
Home > Boards > Free Zone > Health and Sciences > Biotech Values

VX135 + Ribavirin: Enrollment in one study is

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
jq1234 Member Profile
Member Level 
Followed By 48
Posts 3,863
Boards Moderated 0
Alias Born 12/13/09
160x600 placeholder
The European Parliament overwhelmingly approved a resolution that calls for a possible breakup of Google, brushing aside last-minute objections from the U.S. Congress that the move risked politicizing an antitrust investigation.
More Top Equities Stories Of The Day
Spotify's Revenue Rose in 2013, But Losses Continued - 2nd Update
Telefónica Works to Redraw Its Empire
Canada Resident Caught Up in China Corruption Probe
Correction to La Compagnie Fares Story
Appeals Court Grants TV Programmers Stay in FCC Dispute -- Update
SEC Grants Bank of America Short-Term Waiver from Hedge-Fund Restrictions
Kinder Morgan Unveils $6 Billion Debt Offer -- Update
Deere Projects Sharp Decline in Farm-Equipment Sales -- 2nd Update
jq1234 Member Level  Tuesday, 04/30/13 06:49:53 PM
Re: DewDiligence post# 160555
Post # of 184203 
VX135 + Ribavirin: Enrollment in one study is complete, expect data 2nd half this year. I suppose most likely at AASLD in Nov.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist